Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Acute Kidney Injury
Interventions: Aminophylline, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 1 Day to 18 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Breastfeeding
Interventions: Moringa leaf powder, Placebo; Dietary Supplement · Other
Lead sponsor: University of Kentucky; Other
Eligibility: 0 Months and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Obesity
Interventions: Eating breakfast with portion and unportioned foods; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 21 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Spinal Cord Injuries
Interventions: Manually Assisted Locomotor Training, Robotic Assisted Locomotor Training; Procedure · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Treatment of Dry Eye Disease
Interventions: Restasis, Refresh Plus; Drug
Lead sponsor: Innovative Medical; Industry
Eligibility: 13 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: 6400 Fannin Ste 1800, Texas

Conditions: Solid Tumors
Interventions: Screening platform; Other
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 470 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 5
States / cities: Knoxville, Tennessee • Austin, Texas • Tyler, Texas + 2 more

Conditions: Evidence-Based Practice
Interventions: R3; Behavioral
Lead sponsor: Oregon Social Learning Center; Other
Eligibility: 18 Years and older
Enrollment: 404 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Scarring
Interventions: 2-Octyl cyanoacrylate; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Rosacea, Erythema
Interventions: AGN-199201 Dose A, AGN-199201 Dose B, AGN-199201 Dose C, AGN-199201 Vehicle; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 357 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Austin, Texas

Conditions: HIV, Acquired Immunodeficiency Syndrome, Alcoholism, Alcoholic Intoxication, Substance-Related Disorders
Interventions: Motivational Interviewing, Email Feedback, Usual Care; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 100 Years
Enrollment: 614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Amyotrophic Lateral Sclerosis (Healthy Volunteers)
Interventions: SAR443820; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Breast Carcinoma
Interventions: Medical Device Usage and Evaluation, Questionnaire Administration; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Congenital Myotonic Dystrophy
Interventions: Tideglusib, Placebo; Drug
Lead sponsor: AMO Pharma Limited; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 9
States / cities: Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 6 more

Conditions: Type 2 Diabetes
Interventions: Continuous Glucose Monitor and Undermyfork App, Continuous Glucose Monitor; Other
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Delusion of Reference
Interventions: Endocrine Society UL Dosage Vitamin D, Institute of Medicine Dosage Vitamin D, Calcium; Dietary Supplement
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 50 Years to 90 Years · Female only
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Asthma
Interventions: Pediatric ASTHMA-Educator mobile application; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 7 Years to 17 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Major Depressive Disorder (MDD)
Interventions: Cognitive therapy for depression; Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Ischemic Heart Disease
Interventions: Coronary artery bypass - on-pump, Coronary artery bypass - off-pump; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 2,203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 17
States / cities: Palo Alto, California • San Francisco, California • Sepulveda, California + 14 more

Conditions: Bulging, Body Fat
Interventions: truSculpt; Device
Lead sponsor: Cutera Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 3
States / cities: Brisbane, California • Coral Gables, Florida • Naperville, Illinois

Conditions: Osteoarthritis
Interventions: Total knee; Procedure
Lead sponsor: Heekin Orthopedic Research Institute; Other
Eligibility: 21 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Healthy Volunteers
Interventions: GDC-0941, rabeprazole; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: South San Francisco, California

Conditions: B12 Deficiency Vitamin, Energy Supply; Deficiency, Mood
Interventions: Hype Bites Supplement; Dietary Supplement
Lead sponsor: Sourse; Industry
Eligibility: 24 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Vitamin Deficiency
Interventions: EZPAK, Placebo; Dietary Supplement
Lead sponsor: Optimal Health Research; Other
Eligibility: 26 Years to 75 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma
Interventions: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Epacadostat, Laboratory Biomarker Analysis, Pharmacological Study, Poly ICLC; Biological · Drug · Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Buffalo, New York

Search by objective public record fields.

Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery

Moringa Supplementation for Improved Milk Output

Provision of Breakfast Food in Behavioral Weight Loss

Effects of Robotic Versus Manually-Assisted Locomotor Training for Individuals With Incomplete Spinal Cord Injury

Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

Screening Study for Participants With Malignant Tumors

Oregon Supplement: Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy

Aesthetic Outcome of Layered Closure vs. Layered Closure Followed by 2-Octyl Cyanoacrylate

AGN-199201 for the Treatment of Erythema With Rosacea

Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients

A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)

Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7

Study the Effects of Vitamin D and Calcium Supplementation at Tolerable Upper Limit Doses on Calcium Metabolism.

Pediatric ASTHMA-Educator

Improving Depression Outcome by Enhancing Memory for Cognitive Therapy

Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

Multi-Center Pilot Study of truSculpt Device

Anterior Referencing Versus Posterior Referencing in Minimally Invasive Total Knee Arthroplasty

A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers

An Exploratory Investigation of a B12 Vitamin to Increase Energy and Focus

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission